Drug induced nightmares—an etiology based review
Tóm tắt
Recent clinical trials have included patient complaints of nightmares as a category of reportable medication side effects. This study integrates that data into current experimental and theoretical research of drug effects that may alter dreaming and nightmares. The objective is to provide a clinical and theoretical framework useful in categorizing the potential and reported drug effects on nightmares.
This study reviews case reports and clinical trials that have reported nightmares or alterations in dreaming occurring secondary to medication usage. These data are analysed as to the probability of the drug/nightmare association, and integrated into current electrophysiological and neurochemical theories of dreaming and nightmares.
Pharmacological agents affecting the neurotransmitters norepinephrine, serotonin and dopamine are clearly associated with patient reports of nightmares. Agents affecting immunological response to infectious disease are likely to induce nightmares in some patients. A possible association exists between reports of nightmares and agents affecting the neurotransmitters acetylcholine, GABA and histamine, as well as for some anesthetics, antipsychotics and antiepileptic agents.
By utilizing our current experimental and theoretical knowledge base, the potential etiology of a majority of reported drug effects on nightmares can be classified. These data support current neurochemical theories of dreaming, as well as suggesting that the biochemical basis for dreaming and nightmare induction may be more complex than generally suggested. Copyright © 2003 John Wiley & Sons, Ltd.
Từ khóa
Tài liệu tham khảo
Ansoms A, 1991, Zopiclone or lometazepam in the treatment of insomnia and the effect on behavior and mood during the post‐alcoholism withdrawal period, Curr Ther Res, 49, 54
Cohen DB, 1979, Sleep and Dreaming: Origins, Nature and Function
Foulkes D, 1985, Dreaming: A Cognitive‐Psychological Analysis
Francis A, 1994, DSM‐IV—Diagnostic and Statistical Manual of Mental Disorders
Hobson JA, 1986, Handbook of Psychology, 701
Hobson JA, 1994, The Chemistry of Conscious States
Jaffe SE, 2000, Principles and Practice of Sleep Medicine, 1093
Jouvet M, 1999, The Paradox of Sleep: The Story of Dreaming
Krakow B, 1992, Conquering Bad Dreams and Nightmares: A Guide to Understanding, Interpretation and Cure
Krissel J, 1994, Thiopentone, thiopentone/ketamine, and ketamine for induction of anesthesia in caesarean section, Eur J Anaesthesiol, 11, 115
Krueger JM, 2000, Principles and Practice of Sleep Medicine, 255
Krueger JM, 1986, Enhancement of slow wave sleep by endotoxin and libid A, Am J Physiol, 251, R591
Marsh SCU, 1992, Dreaming and anesthesia: total i.v. anaesthesia with propofol versus balanced volatile anaesthesia with enflurane, Eur J Anaesthesiol, 9, 331
McEvoy GK, 2002, AHFS Drug Information, 04
Moffitt A, 1993, The Functions of Dreaming
Pace‐Schott E, 1999, Effects of serotonin reuptake inhibitors (SSRI) on dreaming in normal subjects, Sleep, 22, H278D
Pace‐Schott E, 2000, Enhancement of subjective intensity of dream features in normal subjects by the SSRIs paroxetine and fluvoxamine, Behav Brain Sci, 23, 980
Pace‐SchottEF.Recent findings on the neurobiology of sleep and dreaming. In C.U.P. bookSleep and Dreaming: Scientific Advances and Reconsiderations Based on BBS Special Issue on Sleep and Dreaming(v. 23 December2000).
Pagel JF, 1986, The diagnosis and treatment of insomnia, Am Fam Physic, 35, 191
Pagel JF, 1999, Defining dreaming—a paradigm for comparing interdisciplinary studies of dream, Bull Am Acad Sleep Med, 6, 34
Pagel JF, 2000, Nightmares and disorders of dreaming, Am Family Physic, 61, 2037
Sifton DW, 2002, Physicians' Desk Reference
Solms M, 1997, The Neuropsychology of Dreams—A Clinico‐Anatomical Study
Terr LC, 1987, Sleep and Its Disorders in Children
Thorpy M, 1997, American Sleep Disorders Association, The International Classification of Sleep Disorders, Revised: Diagnostic and Coding Manual
Van Moffaert M, 1990, Comparison of zopiclone and flunitrazepam in the treatment of insomnia in depressed patients, Curr Ther Res, 48, 140